What factors affect dexilation dosage?
patients suffering from erosive esophagitis or neerosive gastroesophage reflux disease often receive treatment with drugs of drugs known as proton pump inhibitors such as Dexilant®. The Lansoprazal, Dexilant® closely related to the United States of the United States and medicinal administrations as treatment of these conditions in 2009. Also known as the general name dexlansoprazole, treatment is assumed that the production of hydrogen acid in the cellular level. While the recommended Dexilant® dose is relatively stable in all populations of patients with a particular condition, it may be appropriate to reduce the overall daily dosage of Dexilant® to 30 mg in patients with more than mild damage to healthy liver function.
Patients receiving the treatment of symptomatic neerosopher reflux disease, Genrally recommended a 30 mg Dexilant® dosage once a day. The standard treatment duration in adults is four weeks. At urThe appropriate dose of Dexilant® for the administration of this condition of the test has only explored the drug as an acute treatment of the disease and has not examined its effects when used for more than six months.
The standard dose of adults for the treatment of erosive esophagitis is higher than the dose needed to control the symptoms of neerosive gastroesofageal reflux disease. Patients should receive one daily oral Dexilant® dosing of 60 mg for eight weeks. Once the status is reasonably checked, a maintenance dose may be given if necessary. The recommended Dexilant® dose to maintain erosive esophagitis in remission is 30 mg administered once a day. Although since 2011 the effects of the drug have been given for periods for more than six months have not been sufficiently studied.
The side effects of the drug are not considered serious. The most common side effects are diarrhea, stomach pain, nausea, vomiting, plYN and increased incidence of upper respiratory tract infections. In extremely rare cases, Dexilant® can cause severe cardiac side effects such as chest pain, water retention, heart palpitations, irregular heart rhythm, angina or heart attack. Some drugs are assumed to interact with Dexilant®. These include, but are not limited to ampicillin, Atazanavir, clopidogrel, digoxin, ketoconazole, tacrolimus and warfarin. In addition, additional iron and certain diuretic drugs can also interact with the action of Dexilant®.